Kinneret Savitsky, Dorit Bitter, Michal Preminger, Aram Adourian, Ken Olisa, Russell Singleton | GenomeWeb

Kinneret Savitsky, VP of biology R&D; Dorit Bitter, VP of computational life sciences R&D; and Michal Preminger, VP of protein therapeutics, will be leaving Compugen, the company said last week. “The three are independent incidences and have nothing to do with one another,” said a Compugen spokeswoman.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.